THE Therapeutic Goods Administration (TGA) has advised pharmacists that shortages of Concerta modified-release tablets will continue until the end of 2026.
The sponsor has said that they will continue to receive supply of Concerta, but it will be variable and there will continue to be periods when supply is limited or when some strengths are unavailable.
Supplies of Teva-XR modified-release tablets are expected to be in shortage until the end of Dec 2025, while Ritalin LA and Rubifen LA capsules will experience interrupted supply until the end of the year.
Additionally, Ritalin 10 mg immediate-release tablets are expected to be in shortage from Aug to Oct.
Substitute overseas-registered products have been approved - see more HERE.
The above article was sent to subscribers in Pharmacy Daily's issue from 18 Jul 25
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 18 Jul 25
